Polygon Management »

Alkami Technology shares owned by Polygon Management

Quarter-by-quarter ownership of Alkami Technology (ALKT) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Alkami Technology

Tip: Access up to 7 years of quarterly data

All positions including Alkami Technology held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkami Technology by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 600k 18.12

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Autolus Therapeutics Spon Ads (AUTL)
Lyft Cl A Com (LYFT)
Definium Therapeutics Com Shs (DFTX)
Workiva Com Cl A (WK)
Silence Therapeutics Ads Call Option (SLN)
Sprinklr Cl A (CXM)
Mbx Biosciences (MBX)
Alkami Technology (ALKT)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)

View all positions for Polygon Management

Top funds holding Alkami Technology

General Atlantic
North Reef Capital Management
JANA Partners Management
UBS Group
BlackRock
Vanguard Portfolio Management
Henderson Group
Algebris
Vanguard Capital Management
Irenic Capital Management
Manufacturers Life Insurance Company
Long Path Partners
Geode Capital Management
State Street Corporation
Citadel Advisors

View all funds holding Alkami Technology